Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus.
Wincup C, Dunn N, Ruetsch-Chelli C, Manouchehrinia A, Kharlamova N, Naja M, Seitz-Polski B, Isenberg DA, Fogdell-Hahn A, Ciurtin C, Jury EC. Wincup C, et al. Among authors: ruetsch chelli c. Rheumatology (Oxford). 2023 Jul 5;62(7):2601-2610. doi: 10.1093/rheumatology/keac608. Rheumatology (Oxford). 2023. PMID: 36370065 Free PMC article.
Low baseline IFN-γ response could predict hospitalization in COVID-19 patients.
Cremoni M, Allouche J, Graça D, Zorzi K, Fernandez C, Teisseyre M, Benzaken S, Ruetsch-Chelli C, Esnault VLM, Dellamonica J, Carles M, Barrière J, Ticchioni M, Brglez V, Seitz-Polski B. Cremoni M, et al. Among authors: ruetsch chelli c. Front Immunol. 2022 Sep 26;13:953502. doi: 10.3389/fimmu.2022.953502. eCollection 2022. Front Immunol. 2022. PMID: 36225915 Free PMC article.
Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients.
Gérard A, Doyen J, Cremoni M, Bailly L, Zorzi K, Ruetsch-Chelli C, Brglez V, Picard-Gauci A, Troin L, Esnault VLM, Passeron T, Montaudié H, Seitz-Polski B. Gérard A, et al. Among authors: ruetsch chelli c. J Immunother Cancer. 2021 Jun;9(6):e002512. doi: 10.1136/jitc-2021-002512. J Immunother Cancer. 2021. PMID: 34088741 Free PMC article. Clinical Trial.
Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis.
Ruetsch-Chelli C, Bresch S, Seitz-Polski B, Rosenthal A, Desnuelle C, Cohen M, Brglez V, Ticchioni M, Lebrun-Frenay C. Ruetsch-Chelli C, et al. Neurotherapeutics. 2021 Apr;18(2):938-948. doi: 10.1007/s13311-021-01006-9. Epub 2021 Mar 25. Neurotherapeutics. 2021. PMID: 33768513 Free PMC article.